L. Valor

553 total citations
49 papers, 319 citations indexed

About

L. Valor is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, L. Valor has authored 49 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Rheumatology, 14 papers in Immunology and 11 papers in Hematology. Recurrent topics in L. Valor's work include Rheumatoid Arthritis Research and Therapies (18 papers), Systemic Lupus Erythematosus Research (12 papers) and Autoimmune and Inflammatory Disorders Research (9 papers). L. Valor is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (18 papers), Systemic Lupus Erythematosus Research (12 papers) and Autoimmune and Inflammatory Disorders Research (9 papers). L. Valor collaborates with scholars based in Spain, Germany and United States. L. Valor's co-authors include Eduardo Fernández‐Cruz, Silvia Sánchez‐Ramón, J. Navarro, Javier Carbone, Carmen Rodríguez-Sáinz, Juana Gil, Georg Schett, Carol Aristimuño, Diana Alecsandru and Clara de Andrés and has published in prestigious journals such as Blood, International Journal of Molecular Sciences and Annals of the Rheumatic Diseases.

In The Last Decade

L. Valor

44 papers receiving 316 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
L. Valor Spain	11	110	105	65	41	38	49	319
Marzieh Tavakol Iran	14	325 3.0×	72 0.7×	35 0.5×	65 1.6×	39 1.0×	50	515
Marlies Blom Netherlands	5	136 1.2×	205 2.0×	72 1.1×	39 1.0×	59 1.6×	5	400
Ewa Więsik–Szewczyk Poland	10	185 1.7×	119 1.1×	39 0.6×	95 2.3×	27 0.7×	56	353
J. Chabod France	13	168 1.5×	49 0.5×	52 0.8×	33 0.8×	27 0.7×	22	430
Lucy C. Fox Australia	11	104 0.9×	15 0.1×	84 1.3×	42 1.0×	37 1.0×	28	322
Yahya Aghighi Iran	11	99 0.9×	97 0.9×	84 1.3×	25 0.6×	17 0.4×	39	300
Liesbeth E. Bakker‐Jonges Netherlands	11	161 1.5×	175 1.7×	29 0.4×	67 1.6×	22 0.6×	22	401
Dana Němcová Czechia	13	80 0.7×	120 1.1×	180 2.8×	63 1.5×	75 2.0×	37	478
Mansour Al‐Janadi Saudi Arabia	11	186 1.7×	140 1.3×	19 0.3×	135 3.3×	33 0.9×	20	418
Bernadete L. Liphaus Brazil	14	215 2.0×	265 2.5×	49 0.8×	206 5.0×	33 0.9×	41	562

Countries citing papers authored by L. Valor

Since Specialization

Citations

This map shows the geographic impact of L. Valor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Valor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Valor more than expected).

Fields of papers citing papers by L. Valor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Valor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Valor. The network helps show where L. Valor may publish in the future.

Co-authorship network of co-authors of L. Valor

This figure shows the co-authorship network connecting the top 25 collaborators of L. Valor. A scholar is included among the top collaborators of L. Valor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Valor. L. Valor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Muehlensiepen, Felix, Yuriy Ignatyev, Christoph Fiehn, et al.. (2023). Healthcare utilization and unmet needs of patients with antisynthetase syndrome: An international patient survey. Rheumatology International. 43(10). 1925–1934. 4 indexed citations

Valor, L., Jochen Wacker, Anja Schmidt, et al.. (2023). „Rheuma (be-)greifen“ – ein multimodales Lehrkonzept zur Verbesserung der rheumatologischen Lehre für Studierende der Humanmedizin. Zeitschrift für Rheumatologie. 83(3). 186–193.

Simons, Gwenda, Ellen M. Janssen, Jorien Veldwijk, et al.. (2022). Acceptable risks of treatments to prevent rheumatoid arthritis among first-degree relatives: demographic and psychological predictors of risk tolerance. RMD Open. 8(2). e002593–e002593. 8 indexed citations

Simons, Gwenda, Jorien Veldwijk, Rachael L. DiSantostefano, et al.. (2022). Preferences for preventive treatments for rheumatoid arthritis: discrete choice survey in the UK, Germany and Romania. Lara D. Veeken. 62(2). 596–605. 10 indexed citations

Pachowsky, Milena, Harriet Morf, David Simón, et al.. (2022). Cinematic rendering in rheumatic diseases—Photorealistic depiction of pathologies improves disease understanding for patients. Frontiers in Medicine. 9. 946106–946106. 10 indexed citations

Valor, L., Bernhard Manger, Jochen Wacker, Arnd Kleyer, & Georg Schett. (2022). Lymph node and pulmonary tuberculosis during upadacitinib treatment in a psoriatic arthritis patient. Rheumatology Advances in Practice. 6(2). rkac032–rkac032. 1 indexed citations

Falahee, Marie, Gwenda Simons, Rachael L. DiSantostefano, et al.. (2021). Treatment preferences for preventive interventions for rheumatoid arthritis: protocol of a mixed methods case study for the Innovative Medicines Initiative PREFER project. BMJ Open. 11(4). e045851–e045851. 8 indexed citations

Corte, Giulia, Sara Bayat, Koray Taşçılar, et al.. (2021). Performance of a Handheld Ultrasound Device to Assess Articular and Periarticular Pathologies in Patients with Inflammatory Arthritis. Diagnostics. 11(7). 1139–1139. 13 indexed citations

Valor, L., Arnd Kleyer, Jürgen Rech, Bernhard Manger, & Georg Schett. (2021). Sustained clinical remission under infliximab/rituximab combination therapy in a patient with granulomatosis with polyangiitis. PubMed. 12(1). 5–5. 7 indexed citations

10.

Sergeeva, Marina G., Sandra Strobelt, Arnd Kleyer, et al.. (2021). Prediction of response to Certolizumab-Pegol in rheumatoid arthritis (PreCePRA) by functional MRI of the brain – Study protocol for a randomized double-blind controlled study. Contemporary Clinical Trials Communications. 22. 100770–100770. 2 indexed citations

11.

Valor, L., Bernhard Manger, Georg Schett, & Arnd Kleyer. (2021). Hepatitis-E-Virus-Infektion bei einem Patienten mit rheumatoider Arthritis unter Baricitinib-Therapie. Zeitschrift für Rheumatologie. 80(10). 980–983. 2 indexed citations

12.

González, Carlos, L. Valor, Juan Carlos Nieto‐González, et al.. (2018). SAT0273 Golimumab retention rate in patients with spondyloarthritis. differences between ankylosing spondylitis and non-radiographic axial spondyloarthritis. Annals of the Rheumatic Diseases. 77. 1001–1001. 2 indexed citations

13.

Morales, José María García Ruiz de, et al.. (2016). Tratamiento con fármacos anti-TNF: utilidad de la monitorización de niveles de fármaco y anticuerpos antifármaco en la práctica clínica. Medicina Clínica. 147(9). 410–416. 2 indexed citations

14.

Hernández-Flórez, Diana, L. Valor, Juan J. Nieto, et al.. (2015). AB0520 Evaluating the Effect of Belimumab on Clinical Disease Activity and B-Cell in Patients with Systemic Lupus Erythematosus. Annals of the Rheumatic Diseases. 74. 1074–1074. 1 indexed citations

15.

Rodríguez-Sáinz, Carmen, L. Valor, Diana Hernández-Flórez, et al.. (2013). Flow Cytometry Analysis with a New FITC-Conjugated Monoclonal Antibody-3E12 for HLA-B*57:01 Rapid Screening in Prevention of Abacavir Hypersensitivity in HIV-1–Infected Patients. HIV Clinical Trials. 14(4). 160–164. 5 indexed citations

16.

Janta, I., Esperanza Naredo, Lina Martínez‐Estupiñán, et al.. (2013). Patient self-assessment and physician's assessment of rheumatoid arthritis activity: which is more realistic in remission status? A comparison with ultrasonography. Lara D. Veeken. 52(12). 2243–2250. 21 indexed citations

17.

Rosas, J., Inmaculada de la Torre, L. Valor, et al.. (2013). THU0206 Clinical Usefulness of Serum Level of Adalimumab, in Patients with Rheumatoid Arthritis. Annals of the Rheumatic Diseases. 72. A233–A234. 2 indexed citations

18.

Valor, L., E. Sarmiento, J. Navarro, et al.. (2012). Evaluation of Lymphoproliferative Responses by Carboxy Fluorescein Succinimidyl Ester Assay in Heart Recipients With Infections. Transplantation Proceedings. 44(9). 2649–2652. 4 indexed citations

19.

Valor, L., Roseta Teijeiro, Carol Aristimuño, et al.. (2010). Estradiol-dependent perforin expression by human regulatory T-cells. European Journal of Clinical Investigation. 41(4). 357–364. 38 indexed citations

20.

Valor, L., J. Navarro, Javier Carbone, et al.. (2008). Immunization with an HIV-1 immunogen induces CD4+ and CD8+ HIV-1-specific polyfunctional responses in patients with chronic HIV-1 infection receiving antiretroviral therapy. Vaccine. 26(22). 2738–2745. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact